Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies
Year: 2017
Type: article
Source: Multiple Sclerosis Journal
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Biogen
OpenAlex ID: W2583602622
